Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M TEMKIN

Showing results (71-80 of 113) with videos related to

Pageof 12
Sort By:
Current Oncology (Toronto, Ont.)|October 28, 2025
A Phase Ib Study of Indirect Immunization with Oregovomab and Toll-like-Receptor-3 Stimulation with Hiltonol<sup>®</sup> in Patients with Recurrent Platinum-Resistant Ovarian CancerRobert W Holloway, Sarah M Temkin, Sarah W Gordon, et al.
Journal of Women'S Health (2002)|April 11, 2023
Public Priorities in Women's Health: Analysis of Request for Information Published to Inform "Advancing NIH Research on the Health of Women: A 2021 Conference"Elizabeth Barr, Samia Noursi, Erik Roodzant, et al.
Communications Medicine|October 27, 2022
Clinical trials and pregnancyCatriona Waitt, Denise Astill, Eleonor Zavala, et al.
Photodermatology, Photoimmunology & Photomedicine|October 3, 2021
Laboratory testing of sunscreens on the US market finds lower in vitro SPF values than on labels and even less UVA protectionDavid Q Andrews, Kali Rauhe, Carla Burns, et al.
Gynecologic Oncology|August 29, 2016
Reducing overtreatment: A comparison of lymph node assessment strategies for endometrial cancerAbdulrahman K Sinno, Elizabeth Peijnenburg, Amanda N Fader, et al.
International Journal of Hygiene and Environmental Health|September 25, 2025
A cumulative dietary pesticide exposure score based on produce consumption is associated with urinary pesticide biomarkers in a U.S. biomonitoring cohortAlexis M Temkin, Varun Subramaniam, Alexa Friedman, et al.
Gynecologic Oncology|January 10, 2022
Creating work environments where people of all genders in gynecologic oncology can thrive: An SGO evidence-based reviewS M Temkin, E Chapman-Davis, N Nair, et al.
Gynecologic Oncology|July 28, 2012
Clinico-pathologic comparison of type II endometrial cancers based on tamoxifen exposureAna I Tergas, Rebecca Buell-Gutbrod, Katja Gwin, et al.
Cancer Causes & Control : CCC|March 3, 2018
Hysterectomy-corrected rates of endometrial cancer among women younger than age 50 in the United StatesSarah M Temkin, Elise C Kohn, Lynne Penberthy, et al.
Frontiers in Oncology|April 25, 2022
Gynecologic Oncology and Inclusion of Women Into the Surgical Workforce: The Canary in This Coal MineLinda J Hong, Lisa Rubinsak, Michelle F Benoit, et al.
Pageof 12

Showing results (71-80 of 113) with videos related to

Sort By:
Pageof 12
Current Oncology (Toronto, Ont.)|October 28, 2025
A Phase Ib Study of Indirect Immunization with Oregovomab and Toll-like-Receptor-3 Stimulation with Hiltonol<sup>®</sup> in Patients with Recurrent Platinum-Resistant Ovarian CancerRobert W Holloway, Sarah M Temkin, Sarah W Gordon, et al.
Journal of Women'S Health (2002)|April 11, 2023
Public Priorities in Women's Health: Analysis of Request for Information Published to Inform "Advancing NIH Research on the Health of Women: A 2021 Conference"Elizabeth Barr, Samia Noursi, Erik Roodzant, et al.
Communications Medicine|October 27, 2022
Clinical trials and pregnancyCatriona Waitt, Denise Astill, Eleonor Zavala, et al.
Photodermatology, Photoimmunology & Photomedicine|October 3, 2021
Laboratory testing of sunscreens on the US market finds lower in vitro SPF values than on labels and even less UVA protectionDavid Q Andrews, Kali Rauhe, Carla Burns, et al.
Gynecologic Oncology|August 29, 2016
Reducing overtreatment: A comparison of lymph node assessment strategies for endometrial cancerAbdulrahman K Sinno, Elizabeth Peijnenburg, Amanda N Fader, et al.
International Journal of Hygiene and Environmental Health|September 25, 2025
A cumulative dietary pesticide exposure score based on produce consumption is associated with urinary pesticide biomarkers in a U.S. biomonitoring cohortAlexis M Temkin, Varun Subramaniam, Alexa Friedman, et al.
Gynecologic Oncology|January 10, 2022
Creating work environments where people of all genders in gynecologic oncology can thrive: An SGO evidence-based reviewS M Temkin, E Chapman-Davis, N Nair, et al.
Gynecologic Oncology|July 28, 2012
Clinico-pathologic comparison of type II endometrial cancers based on tamoxifen exposureAna I Tergas, Rebecca Buell-Gutbrod, Katja Gwin, et al.
Cancer Causes & Control : CCC|March 3, 2018
Hysterectomy-corrected rates of endometrial cancer among women younger than age 50 in the United StatesSarah M Temkin, Elise C Kohn, Lynne Penberthy, et al.
Frontiers in Oncology|April 25, 2022
Gynecologic Oncology and Inclusion of Women Into the Surgical Workforce: The Canary in This Coal MineLinda J Hong, Lisa Rubinsak, Michelle F Benoit, et al.
Pageof 12